ABG Sundal Collier acted as Joint Bookrunner in the DKK 575 million IPO of Gubra – the first IPO on Nasdaq Copenhagen Main Market since 2021

Gubra A/S (“Gubra”), a company specialised in high-end pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases, has successfully completed its initial public offering (“IPO”) on Nasdaq Copenhagen Main Market. The IPO attracted strong interest from Danish and international institutions. The IPO was multiple times oversubscribed, and the Company can welcome more than 1,500 new shareholders. Trading commenced on 30 March 2023.
ATP, Danske Asset Management, Danica Pension and Spar Nord acted as cornerstone investors in the transaction. The IPO was priced at DKK 110 per share, corresponding to a total market value of all issued shares of the Company of c. DKK 1,800 million after completion of the Offering.